GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » Debt-to-EBITDA

Merit Medical Systems (Merit Medical Systems) Debt-to-EBITDA : 3.16 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Merit Medical Systems Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Merit Medical Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $12 Mil. Merit Medical Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $860 Mil. Merit Medical Systems's annualized EBITDA for the quarter that ended in Mar. 2024 was $276 Mil. Merit Medical Systems's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 3.16.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Merit Medical Systems's Debt-to-EBITDA or its related term are showing as below:

MMSI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.48   Med: 3   Max: 4.39
Current: 3.53

During the past 13 years, the highest Debt-to-EBITDA Ratio of Merit Medical Systems was 4.39. The lowest was 1.48. And the median was 3.00.

MMSI's Debt-to-EBITDA is ranked worse than
77.21% of 430 companies
in the Medical Devices & Instruments industry
Industry Median: 1.245 vs MMSI: 3.53

Merit Medical Systems Debt-to-EBITDA Historical Data

The historical data trend for Merit Medical Systems's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems Debt-to-EBITDA Chart

Merit Medical Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.39 4.20 2.03 1.48 3.89

Merit Medical Systems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 1.90 1.44 3.55 3.16

Competitive Comparison of Merit Medical Systems's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's Debt-to-EBITDA falls into.



Merit Medical Systems Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Merit Medical Systems's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.087 + 879.272) / 228.892
=3.89

Merit Medical Systems's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.472 + 860.277) / 276.46
=3.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Merit Medical Systems  (NAS:MMSI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Merit Medical Systems Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Merit Medical Systems (Merit Medical Systems) Business Description

Traded in Other Exchanges
Address
1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. Majority of the revenue is earned from Cardiovascular segment. United States generates majority of the revenue.
Executives
F. Ann Millner director 4275 SPRING ROAD, OGDEN UT 84403
Neil Peterson officer: Chief Operating Officer 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
A Scott Anderson director ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Michel James Voigt officer: Chief Human Resources Officer 1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
Fred P Lampropoulos director, officer: President & CEO
Lynne Ward director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Raul Jr. Parra officer: Interim CFO 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Joseph Wright officer: President, International 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Brian G. Lloyd officer: Chief Legal Officer, Secretary 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost officer: Chief Operating Officer 1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks officer: Chief Strategy & Innovation O. 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Laura S. Kaiser director 10101 WOODFIELD LANE, ST. LOUIS MO 63132
Michael R Mcdonnell director C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Jill Anderson director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans director C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102